Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXCLAIM: Extended VTE Prophylaxis with Lovenox in Acutely Ill Medical Patients
NCT00077753Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2002
- Primary completion
- Oct 2006
- Countries
- 20
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Sanofi. Started Feb 2002; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00077753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077753.